Details for Patent: 10,335,452
✉ Email this page to a colleague
Which drugs does patent 10,335,452 protect, and when does it expire?
Patent 10,335,452 protects TERLIVAZ and is included in one NDA.
This patent has thirty-five patent family members in seventeen countries.
Summary for Patent: 10,335,452
| Title: | Method of treating patients with hepatorenal syndrome type 1 |
| Abstract: | The principles and embodiments of the present disclosure relate to methods for using terlipressin to treat a patient having impaired renal function associated with liver disease. A patient identified as suffering from HRS-1 is tested to determine if the patient meets at least two out of three criteria, wherein the three criteria include a WBC<4 or >12 cells/μL; HR>90 bpm; and any one of HCO<21 mmol/L or PaCO<32 mmHg or >20 breaths per minute. If the patient meets at least two of the criteria, he or she is administered terlipressin in an amount effective to produce a reduction in serum creatinine of at least 1.0 mg/dL. |
| Inventor(s): | Jamil Khurram, Pappas Stephen Chris, Potenziano Jim |
| Assignee: | Mallinckrodt Hospital Products IP Limited |
| Application Number: | US14920392 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 10,335,452
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt Ireland | TERLIVAZ | terlipressin acetate | POWDER;INTRAVENOUS | 022231-001 | Sep 14, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | A METHOD TO IMPROVE KIDNEY FUNCTION IN ADULTS WITH HEPATORENAL SYNDROME WITH RAPID REDUCTION IN KIDNEY FUNCTION | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,335,452
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015335855 | ⤷ Sign Up | |||
| Australia | 2022288996 | ⤷ Sign Up | |||
| Brazil | 112023023894 | ⤷ Sign Up | |||
| Canada | 2965325 | ⤷ Sign Up | |||
| Canada | 3219851 | ⤷ Sign Up | |||
| China | 107206049 | ⤷ Sign Up | |||
| China | 114028536 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
